U.S. Markets closed

Cellectar Biosciences, Inc. (CLRB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.9602-0.0048 (-0.50%)
At close: 4:00PM EDT
0.9501 -0.01 (-1.05%)
After hours: 06:12PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.63
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.9800
52 Week Low 30.8100
50-Day Moving Average 30.9723
200-Day Moving Average 31.3214

Share Statistics

Avg Vol (3 month) 3936.28k
Avg Vol (10 day) 3346.3k
Shares Outstanding 552.73M
Implied Shares Outstanding 6N/A
Float 44.85M
% Held by Insiders 19.54%
% Held by Institutions 138.81%
Shares Short (May 27, 2021) 41.74M
Short Ratio (May 27, 2021) 44.81
Short % of Float (May 27, 2021) 43.31%
Short % of Shares Outstanding (May 27, 2021) 43.29%
Shares Short (prior month Apr 29, 2021) 41.88M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 16, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jul 16, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-34.69%
Return on Equity (ttm)-63.59%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -17.55M
Net Income Avi to Common (ttm)-17.49M
Diluted EPS (ttm)-0.5930
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)53.63M
Total Cash Per Share (mrq)1.02
Total Debt (mrq)392.95k
Total Debt/Equity (mrq)0.79
Current Ratio (mrq)10.84
Book Value Per Share (mrq)0.72

Cash Flow Statement

Operating Cash Flow (ttm)-15.17M
Levered Free Cash Flow (ttm)-8.57M